Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Genflow presents interim re...
BodySpec opens body composi...
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Genflow presents interim re...
BodySpec opens body composi...
João Pedro de Magalhães
Features
Research
Why we age is still longevity’s biggest question
Ecosystem
Research
Mapping the unanswered questions of aging
Ecosystem
When longevity research hits a fiscal headwind
Biotech
Is this the first partial epigenetic reprogramming therapy for the brain?
Research
Aging, biology and the search for longevity’s true drivers
Research
Comparative biology – the hunt for nature’s blueprint for healthspan
Research
Recognizing the driver and passenger mechanisms of aging
Features
Research
Did dinosaurs impact how today’s mammals age?
Features
Can machine learning methods help in extending lifespan?
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report
